Agents that restore acetylcholine (ACh) levels by inhibiting major forms of cholinesterases (i.e., acetylcholinesterase, AChE and butyrylcholinesterase, BChE) have been reported to improve cholinergic transmission in neuronal tissue in the treatment of AD [28]. This evidence concerns the gene BCHE and Alzheimer disease.